Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.

被引：1
|
作者：
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle
Mechtler, Laszlo
Uhlmann, Erik J.
Ciesielski, Michael J.
Fenstermaker, Robert
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Roswell Pk Canc Inst, Buffalo, NY USA
[8] Dent Neurol Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2041
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Patterns of care for 1,602 patients with newly diagnosed glioblastoma.
    Bauchet, Luc
    Zouaoui, Sonia
    Darlix, Amelie
    Rigau, Valerie
    Mathieu-Daude, Helene
    Fabbro-Peray, Pascale
    Fabbro, Michel
    Pallud, Johan
    Bessaoud, Faiza
    Bauchet, Fabienne
    Charissoux, Marie
    Amelot, Aymeric
    Mandonnet, Emmanuel
    Chinot, Olivier L.
    Figarella-Branger, Dominique
    Labrousse, Francois
    Tretarre, Brigitte
    Taillandier, Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [33] The role of postradiation temozolomide in patients with newly diagnosed MGMT methylated glioblastoma.
    Sun, Yuqing
    Romo, Carlos G.
    Shah, Pavan
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] A RANDOMIZED, PHASE I/II TRIAL OF IXAZOMIB IN COMBINATION WITH STANDARD THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED GLIOBLASTOMA (GBM) STUDY DESIGN
    Kong, Xiao-Tang
    Lai, Albert
    Carrillo, Jose A.
    Fu, Dan Beverly
    Meyskens, Frank
    Bota, Daniela A.
    NEURO-ONCOLOGY, 2018, 20 : 13 - 13
  • [35] A phase II study of anlotinib combined with temozolomide in the treatment of patients with recurrent glioblastoma.
    Xu, Qingsheng
    Chen, Qun
    Zheng, Xiujue
    Cai, Jinquan
    Zhan, Renya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
    Roth, Patrick
    Gorlia, Thierry
    Reijneveld, Jaap C.
    de Vos, Filip
    Idbaih, Ahmed
    Frenel, Jean-Sebastien
    Le Rhun, Emilie
    Sepulveda, Juan Manuel
    Perry, James
    Masucci, G. Laura
    Freres, Pierre
    Hirte, Hal
    Seidel, Clemens
    Walenkamp, Annemiek
    Lukacova, Slavka
    Meijnders, Paul
    Blais, Andre
    Ducray, Francois
    Verschaeve, Vincent
    Nicholas, Garth
    Balana, Carmen
    Bota, Daniela A.
    Preusser, Matthias
    Nuyens, Sarah
    Dhermain, Frederic
    van den Bent, Martin
    O'Callaghan, Chris J.
    Vanlancker, Maureen
    Mason, Warren
    Weller, Michael
    NEURO-ONCOLOGY, 2024, 26 (09) : 1670 - 1682
  • [37] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [38] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy post-operatively in patients with newly diagnosed glioblastoma multiforme
    Pecreboom, DM
    Brewer, C
    Stevens, GHJ
    Suh, JH
    Toms, S
    Vogelbaum, MA
    Barnett, GH
    NEURO-ONCOLOGY, 2004, 6 (04) : 379 - 379
  • [39] A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).
    Li, Peijing
    Chen, Yuan Yuan Yuan
    Lai, Shuzhen
    Jiang, Fagui
    Liu, Xiaohui
    Tao, Changjuan
    Wang, Lei
    Liu, Guihong
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Xie, Tieming
    Lu, Fangxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John H.
    Chao, Samuel T.
    Murphy, Erin Sennett
    Yu, Jennifer S.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345